The global Anti-inflammatory Medicine for Pets market size is predicted to grow from US$ 1320 million in 2025 to US$ 1897 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 2.6bn in 2015 to 4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on Chinas Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of Chinas pet medical market is about 67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 50%.

Infinity Market Research newest research report, the Anti-inflammatory Medicine for Pets Industry Forecast looks at past sales and reviews total world Anti-inflammatory Medicine for Pets sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Medicine for Pets sales for 2025 through 2031. With Anti-inflammatory Medicine for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Medicine for Pets industry.

This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Medicine for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-inflammatory Medicine for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Anti-inflammatory Medicine for Pets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Medicine for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Medicine for Pets.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Medicine for Pets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Powder
    Liquid

Segmentation by Application:

    Cat
    Dog
    Reptile
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Wuhan chopperlvya
    CAHIC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-inflammatory Medicine for Pets market?
What factors are driving Anti-inflammatory Medicine for Pets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-inflammatory Medicine for Pets market opportunities vary by end market size?
How does Anti-inflammatory Medicine for Pets break out by Type, by Application?